James D. Stockman, a vice president at Dillard’s, Inc. (DDS), received 13 shares through an award or grant on September 28, 2026, according to the supplied SEC reporting summary. The transaction lists a value of $673.69 per share and a total of approximately $8,758.

The SEC filing report was published on September 29, 2026, at 22:26:50 UTC. Its headline identifies a Form 4 associated with Stockman. The supplied material provides that publication timestamp but does not separately establish the filing’s submission date or time.

What the transaction reports

The reported transaction is a receipt of shares categorized as an award or grant. It should therefore be described as an equity award, rather than a purchase made by Stockman in the market. The summary does not say that he paid cash for the shares.

Multiplying the 13 shares by the stated $673.69 per-share value produces $8,757.97, consistent with the rounded $8,758 total in the source. That calculation describes the reported transaction value; it does not establish cash proceeds or a realized gain for Stockman.

The summary also marks the transaction as having no Rule 10b5-1 plan. That notation concerns the reported award and does not establish whether Stockman has a trading plan covering other activity.

What the filing summary cannot establish

The supplied information does not include Stockman’s total holdings after the award, the grant’s vesting terms or any related restrictions. It also does not explain the reason for this particular grant or place its size within his overall compensation.

Analysis: The disclosure documents an equity award to a named company officer. On its own, it does not demonstrate a discretionary investment decision or establish the officer’s expectations for DDS shares.

What to watch

The full Form 4 and any accompanying footnotes would be the relevant records to check for ownership totals, award conditions and the precise submission date. Those details are not established by the supplied summary.